Overview

Bioequivalence Study Assessing Iron Sucrose or VenoferĀ® in Healthy Adult Subjects

Status:
Completed
Trial end date:
2019-12-18
Target enrollment:
Participant gender:
Summary
This study evaluates the bioequivalence, pharmacokinetic (PK) profile, and safety and tolerability of Iron Sucrose (Test Product) relative to that of VenoferĀ® in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Baxter Healthcare Corporation
Collaborator:
Quotient Sciences
Treatments:
Ferric Oxide, Saccharated
Iron